Pretreatment EGFR T790M Mutation and BRCA1 mRNA Expression in Erlotinib-Treated Advanced Non–Small-Cell Lung Cancer Patients with EGFR Mutations-Reference-Cited by-同舟云学术

Pretreatment EGFR T790M Mutation and BRCA1 mRNA Expression in Erlotinib-Treated Advanced Non–Small-Cell Lung Cancer Patients with EGFR Mutations

Published:2011-01-13 Issue:5 Volume:17 Page:1160-1168
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Rosell Rafael,Molina Miguel Angel,Costa Carlota,Simonetti Sara,Gimenez-Capitan Ana,Bertran-Alamillo Jordi,Mayo Clara,Moran Teresa,Mendez Pedro,Cardenal Felipe,Isla Dolores,Provencio Mariano,Cobo Manuel,Insa Amelia,Garcia-Campelo Rosario,Reguart Noemi,Majem Margarita,Viteri Santiago,Carcereny Enric,Porta Ruth,Massuti Bartomeu,Queralt Cristina,de Aguirre Itziar,Sanchez Jose Miguel,Sanchez-Ronco Maria,Mate Jose Luis,Ariza Aurelio,Benlloch Susana,Sanchez Jose Javier,Bivona Trever G,Sawyers Charles L,Taron Miquel

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 270 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of genomic context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review;Annals of Oncology;2023-12

2. ALDOC promotes non-small cell lung cancer through affecting MYC-mediated UBE2N transcription and regulating Wnt/β-catenin pathway;Aging;2023-09-18

3. BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors;Molecular Cancer;2023-07-13

4. Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations;Journal of Clinical Oncology;2023-06-01

5. Case report: Neuroendocrine breast carcinoma with a germline EGFR T790M mutation;Frontiers in Oncology;2023-05-17